Cargando…
Discovery of Novel Inhibitors of Bacterial DNA Gyrase Using a QSAR-Based Approach
[Image: see text] Type II topoisomerases like DNA gyrase initiate ATP-dependent negative supercoils in bacterial DNA. It is critical in all of the bacteria but is missing from eukaryotes, making it a striking target for antibacterials. Ciprofloxacin is a clinically approved drug, but its clinical ef...
Autores principales: | Jakhar, Ritu, Khichi, Alka, Kumar, Dev, Dangi, Mehak, Chhillar, Anil Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476201/ https://www.ncbi.nlm.nih.gov/pubmed/36120069 http://dx.doi.org/10.1021/acsomega.2c04310 |
Ejemplares similares
-
Advanced In Silico Tools for Designing of Antigenic Epitope as Potential Vaccine Candidates Against Coronavirus
por: Dangi, Mehak, et al.
Publicado: (2018) -
Identification of novel bacterial DNA gyrase inhibitors: An in silico study
por: Rahimi, Hamzeh, et al.
Publicado: (2016) -
Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI
por: Taylor, James A., et al.
Publicado: (2013) -
Discovery of Furanoquinone Derivatives as a Novel Class of DNA Polymerase and Gyrase Inhibitors for MRSA Eradication in Cutaneous Infection
por: Yang, Shih-Chun, et al.
Publicado: (2019) -
Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site
por: Franco-Ulloa, Sebastian, et al.
Publicado: (2018)